Survey: Awareness of COPD - The Nations Fourth Leading Cause Of Death

Nov 2nd of 2009

Diseases Respiratory

Awareness of COPD (chronic obstructive pulmonary disease) continues to grow in the United States, according to national survey results released today by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.

1st New Tobacco Law: Candy and Fruit Flavored Cigarettes Now Illegal in US

Sep 22nd of 2009

General Respiratory

The U.S. Food and Drug Administration announced today a ban on cigarettes with flavors characterizing fruit, candy, or clove. The ban, authorized by the new Family Smoking Prevention and Tobacco Control Act, is part of a national effort by the FDA to reduce smoking in America. Smoking is the leading preventable cause of death in America.

The Impact of Third Hand Smoke on Genes Wins First Prize

May 18th of 2009

Other News Respiratory

A resourceful study into the effect of third hand smoke upon the risk for genetic mutations in fruit flies won the top Addiction Science Award at this year's Intel International Science and Engineering Fair (ISEF), the world's largest science competition for high school students. The Intel ISEF Addiction Science Awards were presented at an awards ceremony last night by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and Friends of NIDA, a group that sup...

Ozone Can Affect Heavier People More

Nov 27th of 2007

General Respiratory

A new study provides the first evidence that people with higher body mass index (BMI) may have a greater response to ozone than leaner people. Short-term exposure to atmospheric ozone has long been known to cause a temporary drop in lung function in many people. This is the first study in humans to look at whether body weight influenced how much lung function falls after acute ozone exposure. Ozone is formed in the atmosphere in the presence of sunlight from other pollutants emitted from vehi...

FDA Approves Zyrtec for Nonprescription Use in Adults and Children

Nov 21st of 2007

Drugs Respiratory

The U.S. Food and Drug Administration has approved tablet, chewable tablet, and syrup formulations of Zyrtec (cetirizine HCl) for nonprescription use. The nonprescription drug is approved for the temporary relief of symptoms due to hay fever or other respiratory allergies (sneezing; runny nose; itchy, watery eyes; itchy throat or nose) in adults and children 2 years of age and older.

ADVERTISEMENT      |      ADVERTISE WITH US